KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Current Assets: 2009-2025

Historic Current Assets for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $12.7 billion.

  • Teva Pharmaceutical Industries' Current Assets rose 3.43% to $12.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 billion, marking a year-over-year increase of 3.43%. This contributed to the annual value of $12.6 billion for FY2024, which is 0.54% up from last year.
  • As of Q3 2025, Teva Pharmaceutical Industries' Current Assets stood at $12.7 billion, which was up 0.92% from $12.6 billion recorded in Q2 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Current Assets peaked at $12.8 billion during Q2 2021, and registered a low of $11.4 billion during Q3 2023.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Current Assets value was $12.3 billion (recorded in 2024), while the average stood at $12.1 billion.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Current Assets dropped by 7.63% in 2023, and later rose by 8.49% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Current Assets (Quarterly) stood at $12.6 billion in 2021, then dropped by 4.15% to $12.1 billion in 2022, then grew by 3.60% to $12.5 billion in 2023, then grew by 0.54% to $12.6 billion in 2024, then grew by 3.43% to $12.7 billion in 2025.
  • Its last three reported values are $12.7 billion in Q3 2025, $12.6 billion for Q2 2025, and $11.5 billion during Q1 2025.